-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on CVS Health, Raises Price Target to $108

Benzinga·08/06/2026 13:19:53
Listen to the news
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $106 to $108.